Research Brief: VILIP-1 a Potential CSF Marker for AD?
treatment, Holtzman told ARF.—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=3098
373 RESULTS
You searched Esther AND Landhuis
Sort By:
treatment, Holtzman told ARF.—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=3098
could be huge,” he said.—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=3093
whether any of this work relates to cells in their native context,” he told ARF.—Esther Landhuis None
PQN-41 to promote linker cell death.—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=3076
treatment.” (See full comment below.)—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=3070
impairment (see ARF related news story).—Esther Landhuis. This is Part 2 of a two-part story. See Part 1.
dominate,” Herz wrote.—Esther Landhuis. This is Part 1 of a two-part story. See Part 2. None
develop AD therapeutic compounds that promote Aβ clearance without actually entering the brain.—Esther
finding (of a longevity variant) is ApoE, which was reported 15 years ago.”—Esther Landhuis None
they will not specify a protocol for clinicians.—Esther Landhuis None
(see ARF related news story).—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=3037
Thompson said.—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=3031 Alzheimer's Disease
premature aging.—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=3023 Aging Research Models
been compared with functional MRI measures.—Esther Landhuis None
themselves may be too damaged. “The wires might be frayed,” Eldaief said.—Esther Landhuis None